A detailed history of Readystate Asset Management LP transactions in Geron Corp stock. As of the latest transaction made, Readystate Asset Management LP holds 12,804 shares of GERN stock, worth $42,765. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,804
Holding current value
$42,765
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$4.17 - $4.99 $53,392 - $63,891
12,804 New
12,804 $58.1 Million
Q1 2024

May 10, 2024

BUY
$1.75 - $3.44 $2.09 Million - $4.1 Million
1,192,200 New
1,192,200 $3.93 Billion

Others Institutions Holding GERN

About GERON CORP


  • Ticker GERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 377,819,008
  • Market Cap $1.26B
  • Description
  • Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...
More about GERN
Track This Portfolio

Track Readystate Asset Management LP Portfolio

Follow Readystate Asset Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Readystate Asset Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Readystate Asset Management LP with notifications on news.